Rejuvenation Technologies Inc.
YC S18mRNA therapeutics to extend healthspan entering clinical trials
San Francisco, CA, USAFounded 20182 employeeswww.rejuvenationtech.com
Team
2
Founded
2018
About
Stanford-patented essential drug platform unlocks the healthspan, which is limited by short telomeres. Extends mouse lifespan by equivalent of 10 years in humans. Reverses 5-10 years of telomere shortening with one dose in one day. Preclinical efficacy in 4 organ systems including immune system. Entering clinical stage. CEO is Subject #1 in longevity trial. 50+ granted patents, 7 patent families. FDA INTERACT cleared. Raising $10M seed extension ($2M+ wired) to fund 3 investigator-initiated trials. Readouts in Q3 2027. $6.8B in comparable mRNA-LNP M&A in last 12 months.
Tags
Anti-Aging Gene Therapy Nanomedicine Healthcare
No open roles at this time.
Similar Healthcare startups
64x Bio
Enabling next generation medicines. A comprehensive platform and…
Gene TherapyMachine Learning
Open Jobs —
Team 25
Founded 2021
Coral Genomics
New clinical tests for managing autoimmune treatments.
Genomics
Open Jobs —
Team 5
Founded 2021
Curebase
Modern, AI-powered clinical trial software platform.
Healthcare
Open Jobs —
Team 27
Founded 2018
HappiLabs
Virtual Lab Managers for scientists and biotech, research Labs
Assistive TechSmart Home AssistantsWarehouse Management Tech
Open Jobs —
Team 14
Founded 2018